Search
Innovative Drug Stocks Experience Volatile Rebound; Kangchen Pharmaceutical and Prism Biolab Reach Daily Limits
2025-08-29 /
Read about 0 minute
Author：小编
On the 29th, innovative drug stocks staged a volatile rebound. Notably, Kangchen Pharmaceutical and Prism Biolab both reached their daily trading limits, while Duorui Pharmaceutical saw gains surpassing 10%. Other companies, including Huahai Pharmaceutical, H&H PharmaTech, Jimin Health, Warner Pharmaceutical, and Medicilon, also posted gains. The National Medical Products Administration revealed that China's pharmaceutical industry ranks second globally in terms of scale, with the number of innovative drugs under research comprising approximately 30% of the global total.
-
C114 Communication Network -
Communication Home
7 X 24 Track global technological trends
